Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3137 - 3144 of 12089 results

PTAB Continues Streak of IPR Denials
June 14, 2021| Blog| Viewpoint

COVID-19 Visa Backlogs, Travel Curbs Strain Businesses in Need of Workers
June 14, 2021| News

In-house Counsel and Pro Bono Work
June 14, 2021| Video| Viewpoint

US State Privacy Law Update – June 11, 2021
June 11, 2021| Blog| Viewpoint

Matching Begins After Millbank Boosted Associate Salaries
June 11, 2021| News

Ninth Circuit Clarifies Requirements on Retroactive Overtime Pay Adjustments for Bonuses
June 10, 2021| Blog| Viewpoint

SPAC Lawsuits Surge Over Disclosure Claims
June 10, 2021| News

Patent Owner Tip #9 for Surviving an Instituted IPR: Issues Warranting Limited Additional Discovery
June 10, 2021| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
